{ 304件 }
Kameda R, Cho KY, Nomoto H, Nakamura A, Omori K, Nagai S, Edagawa S, Kawata S, Takeuchi J, Kameda H, Kurihara Y, Aoki S, Atsumi T, Miyoshi H, LUNA Study Investigators.
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: a multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study) Diabetes Research and Clinical Practice, in press.
IF: 5.602
令和2年度北海道大学医学部エクセレント・ティーチャー（優秀賞） 中沢 大悟先生
令和2年度北海道大学医学部エクセレント・ティーチャー（最優秀賞） 加藤 将先生
Nobuya Abe, Michihito Kono, Ikuko Iwata, Tatsuya Atsumi. Lupus-induced autoimmune chloride channelopathy like myotonia congenita, successfully treated with immunosuppression.
Rheumatology, in press
IF=7.580
Nakamura A, Terauchi Y.
Impaired insulin secretion and related factors in East Asian individuals.
J Diabetes Investig, in press
IF: 3.761
Blencowe M, Furterer A, Wang Q, Gao F, Rosenberger M, Pei L, Nomoto H, Mawla AM, Huising MO, Coppola G, Yang X, Butler PC, Gurlo T.
IAPP induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes Diabetologia, in press.
IF 10.122
Nakazawa D and Kudo T.
Novel Therapeutic Strategy Based on Neutrophil Subset and Its Function in Autoimmune Disease.
Front. Pharmacol, 07 June 2021 https://doi.org/10.3389/fphar.2021.684886
IF; 4.225
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
JAMA. 2021 Jun 1;325(21):2178-2187.
IF: 45.540
Nakamura A, Omori K, Terauchi Y. Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Diabetes Obes Metab, in press
IF: 5.900
Araki T, Tone Y, Yamamoto M, Kameda H, Ben-Shlomo A, Yamada S, Takeshita A, Yamamoto M, Kawakami Y, Tone M, Melmed S Two Distinctive POMC Promoters Modify Gene Expression in Cushing’s Disease J Clin Endocrinol Metab, in press.
IF: 5.399（英文・原著）